CRON - Cronos Group: High Hurdles

• Cronos Group is starting to make progress towards building a business warranting the original big Altria investment.
• The company is still reporting massive EBITDA losses for a business with quarterly revenues of just $25 million.
• The stock isn't appealing until Cronos leaps the large loss hurdle and finally invests the $1 billion cash balance in productive cannabis assets.

For further details see: